Safety of Floracid (Levofloxacin), a Russian Antimicrobial, in the Treatment of Outpatients

Safety of Floracid (Levofloxacin), a Russian Antimicrobial, in the Treatment of Outpatients

Saved in:

Bibliographic Details
Main Author:	S. V. Budanov
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/277
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Dynamics of Reserve Antimicrobial Drug Consumption in Russian Hospitals: Impact of the COVID-19 Pandemic
by: Y. M. Gomon, et al.
Published: (2023-10-01)

Delayed pancytopenia due to treatment with levofloxacin: A case report
by: José Antonio Morales-Molina, et al.
Published: (2018-01-01)

Comparative Analysis of the Use of Antimicrobials With Systemic Action in Outpatients in the Russian Federation, Ukraine and Kazakhstan
by: S. A. Rachina, et al.
Published: (2020-05-01)

Levofloxacin (Tavanic) in Complex Therapy of Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01)

PRODUCTION AND INVESTIGATION OF PROPERTIES OF LIPOSOMAL LEVOFLOXACIN
by: G. М. Sorokoumova, et al.
Published: (2013-10-01)

Photocatalytic Degradation of Levofloxacin and Inactivation of Enterococci Levofloxacin-Resistant Bacteria Using Pure Rare-Earth Oxides
by: Lorenzo Saviano, et al.
Published: (2024-09-01)

Cost-Effectiveness of Oral Levofloxacin Versus Amoxicillin-Clavulanate/Ciprofloxacin for Outpatient Management of Low-Risk Febrile Neutropenia in Children With Cancer in Egypt
by: Reham Abdelaziz Khedr, et al.
Published: (2025-04-01)

Autoimmune Hemolytic Anemia Induced by Levofloxacin
by: Marwan Sheikh-Taha, et al.
Published: (2014-01-01)

Outpatient Parenteral Antimicrobial Therapy
by: Kevin B Laupland, et al.
Published: (2013-01-01)

Novel Levofloxacin Derivatives as Potent Antibacterial Agents
by: Moshafi M. H., et al.
Published: (2017-04-01)

Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment
by: S.E. Purchase, et al.
Published: (2025-03-01)

First experience with a fixed combination of levofloxacin and ketorolac in cataract surgery
by: V. P. Nikolaenko, et al.
Published: (2025-03-01)

Magnesium Orotate Influence on Thoracic Aorta in Laboratory Rabbits Receiving Levofloxacin
by: N. V. Izmozherova, et al.
Published: (2024-10-01)

Synthesis a Number of Heterocyclic Compounds Derived From Levofloxacin
by: Ekram Abdullah Basheer, et al.
Published: (2023-02-01)

Levofloxacin-induced gastrocnemius tendon rupture: a case report
by: Sara Ileri
Published: (2025-05-01)

Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
by: D. T. Wademan, et al.
Published: (2024-02-01)

Levofloxacin loaded PMMA:PVP blended nanofiber mat as an antibacterial material
by: V A Karachevtsev, et al.
Published: (2025-01-01)

HPLC determination, pharmacokinetics and relative bioavailability of levofloxacin produced by «OZONE», Russia
by: S. N. Kondratenko, et al.
Published: (2013-04-01)

Disposition Kinetics of Levofloxacin in Sheep after Intravenous and Intramuscular Administration
by: Ayman Goudah, et al.
Published: (2010-01-01)

Levofloxacin. Expediency of High-Dose Regimens in Therapy of Lower Respiratory Tract Infections
by: I. A. Guchev, et al.
Published: (2020-05-01)

Levofloxacin-induced visual hallucinations: A case report and review of the literature
by: Valentina Raffaelli, et al.
Published: (2018-03-01)

Longitudinal Surveillance of Outpatient Quinolone Antimicrobial Use in Canada
by: Shiona K Glass-Kaastra, et al.
Published: (2014-01-01)

Chitosan/Maleic anhydride and Itaconic acid super porous hydrogels, containing levofloxacin for the treatment of visceral bleeding
by: SYEDA ALEENA UBAID, et al.
Published: (2025-05-01)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01)

Severe Hyponatremia due to Levofloxacin Treatment for Pseudomonas aeruginosa Community-Acquired Pneumonia in a Patient with Oropharyngeal Cancer
by: Mihaela Mocan, et al.
Published: (2016-01-01)

Assessing insurance claims as a measure for outpatient antimicrobial stewardship
by: Mariana M. Lanata, et al.
Published: (2025-01-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS
by: A. A. Lvova, et al.
Published: (2019-01-01)

Development and optimization of levofloxacin in-situ emulgel to manage ocular bacterial infections
by: Sahirul ISLAM, et al.
Published: (2025-02-01)

Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
by: Hafeza Aftab, et al.
Published: (2016-03-01)

EPIDEMIOLOGY OF UNCOMPLICATED OUTPATIENT URINARY TRACT INFECTIONS IN THE RUSSIAN FEDERATION
by: V. V. Rafalsky, et al.
Published: (2018-07-01)

Synthesis a Number of Heterocyclic Compounds and some of chalcones Derived From Levofloxacin
by: Ekram Abdullah Basheer, et al.
Published: (2023-02-01)

Retracted: Clinical Efficacy and Safety Analysis of Levofloxacin for the Prevention of Infection after Traumatic Osteoarthrosis and Internal Fixation: Systematic Review and Meta-Analysis
by: Emergency Medicine International
Published: (2023-01-01)

Thionated levofloxacin derivative: Potential repurposing for cancer treatment and synergism with doxorubicin on doxorubicin-resistant lung cancer cells.
by: Hamza Abumansour, et al.
Published: (2025-01-01)

Thionated levofloxacin derivative: Potential repurposing for cancer treatment and synergism with doxorubicin on doxorubicin-resistant lung cancer cells
by: Hamza Abumansour, et al.
Published: (2025-01-01)

An Analytical View on the Use of Flucloxacillin for Outpatient Parenteral Antimicrobial Therapy
by: Tam Nguyen, et al.
Published: (2024-10-01)

Key issues of patient safety during anticancer drug treatment in a day hospital and outpatient setting
by: A. A. Fedenko, et al.
Published: (2021-11-01)

Evaluation of the effect of Levofloxacin and Cefalexin derivative antibiotics on Implant Osseointegration in rat tibia
by: Umit Koray Can, et al.
Published: (2025-07-01)

Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland
by: Elżbieta Karczewska, et al.
Published: (2012-01-01)

Is There an Apparent Difference in the Activity of Amikacin, Levofloxacin, and other Antibiotics Against Staphylococcus Species?
by: Ali Abedulameer Alhusayni, et al.
Published: (2024-07-01)